Posted Feb. 24, 2012 at 6:45 a.m.

Premium Lock FDA panel OKs Charlotte-based Chelsea's Parkinson's drug

Published: 2012-02-24 06:45:14
Updated: 2012-02-24 06:45:14


The 7-4 vote with one abstention and one "non-vote" from the independent panel does not bind the FDA to rule one way or another on the drug. But the vote of confidence in the compound does run counter to the conclusion of the FDA's own staffers, who were concerned about Northera's short duration and possible safety issues that arose during clinical trials....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders